血红素
生物
髓系白血病
生物合成
酶
细胞生物学
生物化学
细胞培养
白血病
K562细胞
代谢物
髓样
HEK 293细胞
信号转导
下调和上调
细胞色素P450
突变
癌症研究
基因
功能(生物学)
细胞
干细胞
程序性细胞死亡
基因表达
血红素加氧酶
线粒体
细胞毒性
基因表达调控
点突变
作者
Alexander Charles Lewis,Emily Gruber,Rheana L. Franich,Jessica M. Armstrong,Madison J. Kelly,Carlos Opazo,Yau Chung Low,Léa Flippe,Kevin Julio Wijanarko,Caitlin L. Rowe,Celeste Mawal,Alexandra M. Birrell,Joan So,Srimayee Vaidyanathan,Keziah Ting,Liana N. Semcesen,Karena Last,Ching‐Seng Ang,Giovanna Pomilio,Fiona C. Brown
出处
期刊:Cell
[Cell Press]
日期:2025-11-19
卷期号:189 (1): 215-232.e24
被引量:41
标识
DOI:10.1016/j.cell.2025.10.028
摘要
The ubiquitous metabolite heme has diverse enzymatic and signaling functions in most mammalian cells. Through integrated analyses of mouse models, human cell lines, and primary patient samples, we identify de novo heme biosynthesis as a selective dependency in acute myeloid leukemia (AML). The dependency is underpinned by a propensity of AML cells, and especially leukemic stem cells (LSCs), to downregulate heme biosynthesis enzymes (HBEs), which promotes their self-renewal. Inhibition of HBEs causes the collapse of mitochondrial Complex IV and dysregulates the copper-chaperone system, inducing cuproptosis, a form of programmed cell death brought about by the oligomerization of lipoylated proteins by copper. Moreover, we identify pathways that are synthetic lethal with heme biosynthesis, including glycolysis, which can be leveraged for combination strategies. Altogether, our work uncovers a heme rheostat that is connected to gene expression and drug sensitivity in AML and implicates HBE inhibition as a trigger of cuproptosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI